News - Greater Bay Area International Clinical Trial Institute

22.12.2025

Establishment of Real-World Study and Application Centre and simultaneous launch of GBA Clinical Trial Collaboration Platform

The Greater Bay Area International Clinical Trial Institute (GBAICTI) is pleased to announce the establishment of the Real-World Study and Application Centre (RWSAC), and the launch of the GBA Clinical Trial Collaboration Platform.

08.12.2025

Career Talk: Discover Your Future in Healthcare & Pharmaceuticals

Join us for an inspiring Career Talk featuring two distinguished HKU alumni, Sara Chan (Clinical Operations Lead, Roche) and Jessie Yip (Project Director, Fortrea), as they share their professional journeys and insights into the dynamic healthcare and pharmaceutical industries.

21.11.2025

Workshop on Strategic Application of Real-World Data

The Greater Bay Area International Clinical Trial Institute (GBAICTI) proudly convened its exclusive workshop, "Strategic Application of Real-World Data," on November 21, 2025. The event brought together key partners from the pharmaceutical industry for an in-depth exploration of the transformative role of Real-World Data (RWD) and Real-World Evidence (RWE) in the modern drug development landscape.

13.11.2025

Public hospitals in Hong Kong now experience smoother initiation processes for industry-sponsored clinical studies, thanks to new Clinical Site Agreement (CSA) management initiative.

We are pleased to share the latest progress on the Clinical Site Agreement (CSA) management initiative, launched in April 2025 with full support from The University of Hong Kong Clinical Trials Centre (HKU-CTC).

03.11.2025

GBAICTI welcomes being included into Immigration Facilitation Scheme for Visitors Participating in Short-term Activities in Designated Sectors

The Greater Bay Area International Clinical Trial Institute (GBAICTI) welcomes being added by the Hong Kong Special Administrative Region (HKSAR) Government to the "Immigration Facilitation Scheme for Visitors Participating in Short-term Activities in Designated Sectors", becoming an authorized organization under the medical and healthcare sector. The new arrangement will take effect from November 1, 2025.

17.10.2025

GBAICTI Joins Key Medical Innovation Discussion in Macau

Professor Bernard Cheung, CEO of the GBAICTI, shared his expert vision for the future of regional medical research at the "Greater Bay Area Clinical Trial and Medical Innovation Forum" in Macau.